Shares of Horizon Pharma (Nasdaq: HZNP) climbed $1.25 to close at $13.14 on news that the implementation of certain regulations related to drug prices will be delayed.
Horizon Pharma climbs on regulation delay
August 17, 2017 at 17:27 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.